BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8095516)

  • 1. Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.
    Podzamczer D; Bolao F; Clotet B; García P; Casanova A; Pagerols X; Gudiol F
    J Intern Med; 1993 Mar; 233(3):247-53. PubMed ID: 8095516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and tolerance of low-dose, long-term interferon-alpha 2b and zidovudine in early-stage AIDS-associated Kaposi's sarcoma.
    Mauss S; Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):157-62. PubMed ID: 7552479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
    Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
    Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined zidovudine and interferon-alpha treatment in patients with AIDS-associated Kaposi's sarcoma.
    de Wit R; Danner SA; Bakker PJ; Lange JM; Eeftinck Schattenkerk JK; Veenhof CH
    J Intern Med; 1991 Jan; 229(1):35-40. PubMed ID: 1995761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma.
    Dupuy J; Price M; Lynch G; Bruce S; Schwartz M
    J Am Acad Dermatol; 1993 Jun; 28(6):966-72. PubMed ID: 8496462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
    Fischl MA; Finkelstein DM; He W; Powderly WG; Triozzi PL; Steigbigel RT
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):379-84. PubMed ID: 8601224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
    Baumann R; Täuber MG; Opravil M; Hirschel B; Kinloch S; Chave JP; Pletscher M; Lüthy R
    Klin Wochenschr; 1991 May; 69(8):360-7. PubMed ID: 1909399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    Am J Clin Oncol; 1991; 14 Suppl 1():S40-4. PubMed ID: 2048563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
    Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
    J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
    Mitsuyasu RT
    Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma.
    Lane HC; Kovacs JA; Feinberg J; Herpin B; Davey V; Walker R; Deyton L; Metcalf JA; Baseler M; Salzman N
    Lancet; 1988 Nov; 2(8622):1218-22. PubMed ID: 2903954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.
    Paredes J; Krown SE
    Int J Immunopharmacol; 1991; 13 Suppl 1():77-81. PubMed ID: 1823908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.
    de Wit R; Schattenkerk JK; Boucher CA; Bakker PJ; Veenhof KH; Danner SA
    Lancet; 1988 Nov; 2(8622):1214-7. PubMed ID: 2903953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.
    Shepherd FA; Beaulieu R; Gelmon K; Thuot CA; Sawka C; Read S; Singer J
    J Clin Oncol; 1998 May; 16(5):1736-42. PubMed ID: 9586886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group.
    Fernández-Cruz E; Lang JM; Frissen J; Furner V; Châteauvert M; Boucher CA; Dowd P; Stevens J
    AIDS; 1995 Sep; 9(9):1025-35. PubMed ID: 8527074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
    Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
    Gill PS
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
    Kovacs JA; Deyton L; Davey R; Falloon J; Zunich K; Lee D; Metcalf JA; Bigley JW; Sawyer LA; Zoon KC
    Ann Intern Med; 1989 Aug; 111(4):280-7. PubMed ID: 2757312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.